期刊文献+

急性白血病并发出血患者的止凝血特点及其与预后的关系 被引量:5

Clinical and prognostic significance of hemostatic molecular markers in acute leukemia with bleeding
下载PDF
导出
摘要 目的 :研究急性白血病 (AL)并发不同程度出血患者的止凝血异常特点及其与预后的关系。方法 :采用ELISA方法检测 93例AL患者血浆组织因子 (TF)、组织因子途径抑制物 (TFPI)、凝血酶 抗凝血酶复合物(TAT)、纤溶酶 抗纤溶酶复合物 (PAP)、尿激酶型纤溶酶原激活物 (u PA)、尿激酶型纤溶酶原激活物受体 (u PAR)、D 二聚体 (D D)的含量。结果 :仅有TF、TAT、D D升高者 ,临床上大多表现为轻度出血 ;除TF、TAT、D D显著升高外 ,还伴有u PA、u PAR、PAP高于无出血对照组者 ,临床上以重度出血为主。TAT、PAP、D D对弥散性血管内凝血前期 (pre DIC)诊断的灵敏度分别为 88.5 7%、97.14%和 85 .70 % ,特异性为 69.5 7%、76.0 9%和89.13 % ;联合应用三个指标 ,其灵敏度为 80 .0 0 % ,特异性为 95 .65 %。u PA、u PAR持续增高者预后差 ,2年无复发生存率 (RFS)和 2年总生存率 (OS)显著降低。结论 :轻度出血主要由高凝、继发性纤溶亢进等引起 ,而原发性纤溶亢进则是重度出血最主要的原因 ;TAT、PAP、D D对 pre DIC的诊断有重要意义 ;多项分子标志物的联合应用可提高pre DIC的确诊率。TF对DIC的发展和进程具有预示作用。u PA、u Objective:To study the characteristic of hemostatic disorders in acute leukemia(AL) and their relationship with bleeding symptom and prognosis.Method:A series of hemostatic molecular markers, including TAT,TF,TFPI,PAP ,u-PA ,u-PAR and D-D were measured in 93 patients with acute leukemia (AL) .Result:Plasma levels of TAT,TF,D-D were higher in patients with mild bleeding while PAP,u-PA,u-PAR level were markedly elevated in patients with severe bleeding. The sensitivity of TAT,PAP and D-D for the diagnosis of pre-DIC were 88.5% , 97.14% and 85.70%, whereas the specificity of those molecular markers for the diagnosis of pre-DIC were 69.57%, 76.09% and 89.13%. By combining the results of TAT,PAP and D-D, diagnostic sensitivity was 80%,diagnostic specificity was 95.56%. Persistent high levels of u-PA,u-PAR were correlated with short duration of relapse-free survival (RFS) and overall survival (OS).Conclusion:Hyperfibrinolysis might be the main reason of bleeding in patients with sever hemorrhage,While hemostatic disorder in patients with mild hemorrhage was hypercoagulability; The hemostatic molecular markers TAT,PAP and D-D were useful for the diagnosis of pre-DIC, while combinations of hemostatic molecular markers increases the specificity of diagnosis. TF was an important marker to predict the development and prognosis of DIC. u-PA, u-PAR may be considered as useful markers for prognosis.
出处 《临床血液学杂志》 CAS 2003年第4期156-159,共4页 Journal of Clinical Hematology
关键词 白血病 急性 出血 止血 预后 Leukemia,acute Bleeding Hemostasis Prognosis
  • 相关文献

参考文献7

  • 1中华医学会血液分会血栓与止血组.弥散性血管内凝血前期(pre—DIC)诊断标准[J].中国实验诊断学,2000,2:93-96.
  • 2Cho Jnowski K, Trelinski J, Wawrzyniak E, et al. The influence of low molecular weight heparin on the intravascular activation of the coagulation system in patients with acute leukemia during induction chemotherapy-report of a prospective randomized study. Leuk Lymphoma, 2002,43:1021-1028.
  • 3Wada H, Gabazza E, Nakaski. Diagnosis of disseminated intravascular coagulation by hemastatic molecular markers. Semin Thromb Hemost, 2000,26 : 17- 21.
  • 4Asakura H, Ontachi Y, Mizutani T, et al. Elevated levels of free tissue factor pathway inhibitor antigen in case of disseminated intravascular coagulation caused by various underlying diseases. Blood Coagul Fibrinolysis,2001,12:1-81.
  • 5Okugawa Y, Wada H, Noda T, et al. Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation. Am J Haematol, 2000,65 : 557- 563.
  • 6Lanza F, Castoldi G L, Castagnari B, et al. Expression and functional role of u-PAR in normal and acute leukemia cells. British Journal of Haematology, 1998, 103:110-123.
  • 7Shinji N, Ken-ichi I, Minoru F, et al. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal banters . Int J Cancer, 1999, 79:179-186 .

同被引文献50

  • 1张宏,梁建英,李军,傅晋翔.急性早幼粒细胞白血病患者凝血纤溶指标的检测与分析[J].苏州大学学报(医学版),2004,24(4):521-522. 被引量:8
  • 2谢燕,王兆钺,张威,戴兰,白霞.白血病细胞系纤溶活性及全反式维甲酸对其影响[J].中华血液学杂志,2006,27(9):588-592. 被引量:6
  • 3徐兵,唐家宏,李琳,李冰.血液肿瘤患者FLT3/ITD基因突变的检测及临床意义[J].中国实用内科杂志,2007,27(14):1113-1115. 被引量:4
  • 4KWAAN H C,VICUNA B. Incidence and pathogenesis of thrombosis in hematologic malignancies[J]. Semin Thromb Hemost, 2007,33 : 303- 312.
  • 5JABBOUR E J, ESTEY E, KANTARJIAN H M. Adult acute myeloid leukemia [J]. Mayo Clln Proc, 2006,81 : 247- 260.
  • 6TALLMAN M S, ABUTALIB S A,ALTMAN J K. The double hazard of thrombophilia and bleeding in a cute promyelocytic leukemia[J]. Semin Thromb Hemost, 2007,33 : 330- 338.
  • 7RODEGHIERO F, CASTAMAN G, TOSETTO A, et al. The diseriminant power of bleeding history for the diagnosis of type 1 yon Willebrand disease: an international,multicenter study[J]. J Thromb Haemost,2005,3 : 2619-2626.
  • 8HAJJAR K A,KRISHNAN S. Annexin Ⅱ : a media tor of the plasmin/plasminogen activator system[J]. Trends Cardiovasc Med, 1999,9 : 128 - 138.
  • 9BENE M C, CASTOLDI G, KNAPP W, et al. CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders[J]. Leukemia,2004,18:394-400.
  • 10MENELL J S,CESARMAN G M,JACOVINA A T, et al. Annexin Ⅱ and bleeding in acute promyelocytic leukemia[J]. N Engl J Med, 1999,340 : 994- 1004.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部